Please wait
0001585364S-3ASREX-FILING FEESOrdinary Stock, nominal value 0.001 per share, of Perrigo Company plc00000000 0001585364 2024-09-09 2024-09-09 0001585364 2 2024-09-09 2024-09-09 0001585364 3 2024-09-09 2024-09-09 0001585364 4 2024-09-09 2024-09-09 0001585364 5 2024-09-09 2024-09-09 0001585364 6 2024-09-09 2024-09-09 0001585364 1 2024-09-09 2024-09-09 iso4217:USD
Exhibit 107.1
Calculation of Filing Fee Table
Form
S-3
(Form Type)
Issuer:
Perrigo Company plc
Perrigo Finance Unlimited Company
Guarantors:
Athena Neurosciences, LLC
Chefaro Ireland Designated Activity Company
Elan Pharmaceuticals, LLC
Galpharm Healthcare Limited
Galpharm International Limited
Gr8ness, LLC
L. Perrigo Company
Medgenix Benelux NV
OCE-BIO
BV
Perrigo Belgium NV
Perrigo Capital NV
Omega Pharma Innovation & Development NV
Omega Pharma International NV
Omega Pharma Limited
Omega Pharma Trading NV
Omega Teknika Designated Activity Company
PBM Canada Holdings, LLC
PBM Nutritionals, LLC
PBM Products, LLC
Perrigo Americas Holdings, Inc.
Perrigo Company
Perrigo Corporation Designated Activity Company
Perrigo Diabetes Care, LLC
Perrigo Direct, Inc.
Perrigo Europe Invest NV
Perrigo Finance (US) LLC
Perrigo Florida, Inc.
Perrigo Holding NV
Perrigo Holdings Unlimited Company
Perrigo International Finance Designated Activity Company
Perrigo International Holdings II, Inc.
Perrigo International Holdings, LLC
Perrigo International, Inc.
Perrigo Investments, LLC
Perrigo Ireland 1 Designated Activity Company
Perrigo Ireland 10 Unlimited Company
Perrigo Supply Chain International Designated Activity Company
Perrigo Ireland 13 Designated Activity Company
Perrigo Ireland 2 Designated Activity Company
Perrigo Ireland 4 Unlimited Company
Perrigo Ireland 5 Unlimited Company
Perrigo Ireland 6 Unlimited Company
Perrigo Ireland 9 Unlimited Company
Perrigo Management Company
Perrigo Mexico Investment Holdings, LLC
Perrigo New York, Inc.
Perrigo Pharma International Designated Activity Company
Perrigo Pharma Limited

Perrigo Research & Development Company
Perrigo Sales Corporation
Perrigo Science One Designated Activity Company
Perrigo UK Acquisition Limited
PMI Branded Pharmaceuticals, Inc.
Ranir Global Holdings, LLC
Ranir (Holdings) Limited
Ranir, LLC
Wrafton Laboratories Limited
(Exact Name of Registrant as Specified in its Charter)
 
 
Table 1: Newly Registered and Carry Forward Securities
 
                         
    
Security
Type
  Security
Class
Title
 
Fee
Calculation
or Carry
Forward
Rule
 
Amount
Registered
 
Proposed
Maximum
Offering
Price Per
Unit
 
Maximum
Aggregate
Offering
Price
 
Fee
Rate
 
Amount of
Registration
Fee
 
Carry
Forward
Form
Type
 
Carry
Forward
File
Number
 
Carry
Forward
Initial
effective
date
 
Filing Fee
Previously
Paid in
Connection
with
Unsold
Securities
to be
Carried
Forward
 
Newly Registered Securities
                         
Fees to Be
Paid
  Debt   Debt Securities of Perrigo Company plc  
Rule
456(b)
and
Rule
457(r)(1)
  (1)   (1)   (1)   (1)   (1)          
                         
    Debt   Debt Securities of Perrigo Finance Unlimited Company  
Rule
456(b)
and
Rule
457(r)(1)
  (1)   (1)   (1)   (1)   (1)          
                         
    Debt   Guarantees by Perrigo Company plc of Debt Securities (2)  
Rule
456(b)
and
Rule
457(r)(1)
  (1)   (1)   (1)   (1)   (1)          
                         
    Debt   Guarantees by Perrigo Finance Unlimited Company of Debt Securities (2)  
Rule
456(b)
and
Rule
457(r)(1)
  (1)   (1)   (1)   (1)   (1)          
                         
    Equity  
Ordinary Stock, nominal value €0.001 per share, of Perrigo Company plc
 
Rule 456(b)
and
Rule 457(r)(1)
  (1)   (1)   (1)   (1)   (1)          
                         
    Equity   Preferred Stock, nominal value of $0.0001 per share, of Perrigo Company plc  
Rule 456(b)
and
Rule 457(r)(1)
  (1)   (1)   (1)   (1)   (1)          
                         
Fees
Previously
Paid
                         
 
Carry Forward Securities
                         
Carry
Forward
Securities
                       
                   
    Total Offering Amounts       $ —     $ —          
                   
    Total Fees Previously Paid           $ —          
                   
    Total Fee Offsets           $ —          
                   
    Net Fee Due                 $ —                
(1)
An indeterminate amount of securities to be offered at indeterminate prices is being registered pursuant to this registration statement. In accordance with Rule 456(b) and Rule 457(r) under the Securities Act of 1933, as amended, the registrant is deferring payment of the registration fee.
(2)
Pursuant to Rule 457(n) under the Securities Act, no additional registration fee is being paid in
respect
of the guarantees. The guarantees do not trade separately.